Summary of Stratasys Ltd. Q3 2025 Earnings Call

1Key Financial Results and Metrics

Revenue: Consolidated revenue was $137 million, a decline of 2.1% year-over-year.

Product Revenue: Flat at $94.1 million; system revenue increased slightly to $32.1 million.

Service Revenue: Decreased to $42.9 million from $45.9 million year-over-year.

Gross Margin: GAAP gross margin fell to 41% from 44.8% in the prior year; non-GAAP gross margin was 45.3%, down from 49.6%.

Operating Expenses: GAAP operating expenses were $78.8 million (57.5% of revenue), down from $88.2 million (63% of revenue) year-over-year.

Net Loss: GAAP net loss was $55.6 million ($0.65 per share), compared to a loss of $26.6 million ($0.37 per share) in Q3 2024, primarily due to a non-cash impairment charge of $33.9 million related to Ultimaker.

Non-GAAP Net Income: Reported at $1.5 million ($0.02 per share), up from $400,000 ($0.01 per share) in the same period last year.

Cash Flow: Generated $6.9 million in operating cash flow, an improvement from a $4.5 million outflow in Q3 2024. Cash reserves stood at $255 million with no debt.

2Strategic Updates and Business Highlights

Focus on operational excellence and customer partnerships to drive growth in high-value sectors like aerospace, defense, and automotive tooling.

Notable wins in aerospace with customers like Boeing and Embraer, and in defense with Honeywell and L3 Harris.

Participation in Trident Warrior 25 showcased Stratasys' capabilities in distributed advanced manufacturing for military applications.

New strategic partnerships, including a significant investment from a major U.S. tech company for large-scale prototyping and future production parts.

Launch of new dental solutions and the hiring of Chris Cabot to lead dental initiatives, emphasizing a commitment to innovation and market leadership.

3Forward Guidance and Outlook

Reaffirmed full-year 2025 revenue guidance of $550 million to $560 million.

Non-GAAP gross margin expected to range from 46.7% to 47%, with operating margin projected between 1.5% to 2%.

Adjusted earnings per share forecasted at $0.13 to $0.16, with adjusted EBITDA expected to be between $30 million and $32 million.

Anticipated improvement in gross margin starting in Q4 2025 due to price increases and cost management efforts.

4Bad News, Challenges, or Points of Concern

Continued macroeconomic pressures impacting capital equipment spending, contributing to revenue declines.

Gross margin compression due to increased tariffs (raised from 10% to 15%) and changes in product mix.

The significant GAAP net loss attributed to a non-cash impairment charge raises concerns about investment performance.

The sales cycle for new production applications remains lengthy, with uncertainty around timing for revenue contributions from new customers.

5Notable Q&A Insights

Management expressed optimism about gross margin recovery, expecting improvements in Q4 and into 2026 due to pricing strategies.

The focus remains on high-end manufacturing applications, with a strategic shift away from lower-end rapid prototyping.

The company is confident in its position in premium markets, particularly aerospace and defense, and is seeing early signs of improvement in sales cycles.

Concerns were raised about consumables revenue, which has not grown as expected, but management indicated that increased sales of high-end machines would drive future consumables growth. This summary encapsulates the key points from Stratasys' Q3 2025 earnings call, highlighting both the company's achievements and ongoing challenges.